Literature DB >> 10941986

Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life".

R Pukrop1, H J Möller, E M Steinmeyer.   

Abstract

The aim of the present study is to contribute to an ongoing validation process of the Quality of Life (QoL) construct in the clinical field by investigating its internal structure. Eight (inter)nationally validated questionnaires have been analyzed by an integrative approach in a multicenter study. Data has been collected in a mentally healthy (n = 479), a depressed (n = 171) and a schizophrenic (n = 139) sample. Apart from conventional psychometric criteria a similarity structure analysis (SSA) within a facet analytic methodology has been applied. A dimensional structure of the resulting integrative questionnaire "Modular System for Quality of Life" (MSQoL) could be generated that consists of one "G-factor" (life in general) and six specific dimensions (physical health, vitality, psychosocial relationships, material resources, affect, leisure time). This basic structure represents a core module measured by 47 items which is sufficiently valid for all three samples. The empirical structures of healthy, depressed and schizophrenic samples fulfill the first law of attitude and share a common variance of 95%. In addition, there are four specific modules (demography, family, partnership, profession). No specific modules could be identified for the psychopathological subgroups. The conclusion can be drawn that QoL is construed very similar by all three investigated populations which is the base for searching for quantitative differences and profiles. The MSQoL integrates the non-redundant components of eight QoL-instruments, is psychometrically able to assess the basic structure and can be completed within a cumulative research design by items specific for a particular setting.

Entities:  

Mesh:

Year:  2000        PMID: 10941986     DOI: 10.1007/s004060070028

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  18 in total

1.  The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.

Authors:  Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Don Linszen; Max Birchwood; Georg Juckel; Anthony Morrison; José Luis Vázquèz-Barquero; Martin Hambrecht; Heinrich VON Reventlow
Journal:  World Psychiatry       Date:  2005-10       Impact factor: 49.548

Review 2.  Multidimensional scaling as a tool for analysing quality of life data.

Authors:  G Kemmler; B Holzner; M Kopp; M Dünser; R Greil; E Hahn; B Sperner-Unterweger
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

3.  Discriminant and convergent validity of a subjective quality-of-life instrument aimed at high content validity for schizophrenic persons.

Authors:  M Franz; M Fritz; T Meyer
Journal:  Qual Life Res       Date:  2012-06-22       Impact factor: 4.147

Review 4.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

Review 5.  Quality of life and subthreshold affective symptoms.

Authors:  Arianna Goracci; Mirko Martinucci; Umberto Scalcione; Andrea Fagiolini; Paolo Castrogiovanni
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

6.  The impact of mental illness on quality of life: A comparison of severe mental illness, common mental disorder and healthy population samples.

Authors:  Sherrill Evans; Sube Banerjee; Morven Leese; Peter Huxley
Journal:  Qual Life Res       Date:  2006-10-12       Impact factor: 4.147

7.  Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction.

Authors:  J Kuhn; M Möller; J F Treppmann; C Bartsch; D Lenartz; T O J Gruendler; M Maarouf; A Brosig; U B Barnikol; J Klosterkötter; V Sturm
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

8.  The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis.

Authors:  C M Corcoran; D Kimhy; M A Parrilla-Escobar; V L Cressman; A D Stanford; J Thompson; S Ben David; A Crumbley; S Schobel; H Moore; D Malaspina
Journal:  Psychol Med       Date:  2010-05-06       Impact factor: 7.723

Review 9.  Do effectiveness ("real world") studies on antipsychotics tell us the real truth?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-07-11       Impact factor: 5.270

10.  The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life.

Authors:  A Karow; F-G Pajonk; J Reimer; F Hirdes; C Osterwald; D Naber; S Moritz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.